Follow
Manasi Kiran Mayekar, PhD
Manasi Kiran Mayekar, PhD
Senior Scientist II (AbbVie)
No verified email - Homepage
Title
Cited by
Cited by
Year
Current landscape of targeted therapy in lung cancer
MK Mayekar, TG Bivona
Clinical Pharmacology & Therapeutics 102 (5), 757-764, 2017
1632017
Structural basis for Spt5-mediated recruitment of the Paf1 complex to chromatin
AD Wier, MK Mayekar, A Héroux, KM Arndt, AP VanDemark
Proceedings of the National Academy of Sciences 110 (43), 17290-17295, 2013
1062013
C/EBPγ Is a Critical Regulator of Cellular Stress Response Networks through Heterodimerization with ATF4
PFJ Christopher J Huggins, Manasi K Mayekar, Nancy Martin, Karen L Saylor ...
Molecular and cellular biology 36 (5), 693-713, 2016
982016
The Recruitment of the Saccharomyces cerevisiae Paf1 Complex to Active Genes Requires a Domain of Rtf1 That Directly Interacts with the Spt4-Spt5 Complex
MK Mayekar, RG Gardner, KM Arndt
Molecular and cellular biology 33 (16), 3259-3273, 2013
692013
Small region of Rtf1 protein can substitute for complete Paf1 complex in facilitating global histone H2B ubiquitylation in yeast
AS Piro, MK Mayekar, MH Warner, CP Davis, KM Arndt
Proceedings of the National Academy of Sciences 109 (27), 10837-10842, 2012
692012
Differential subcellular localization regulates oncogenic signaling by ROS1 kinase fusion proteins
DS Neel, DV Allegakoen, V Olivas, MK Mayekar, G Hemmati, ...
Cancer research 79 (3), 546-556, 2019
652019
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer
S Nanjo, W Wu, N Karachaliou, CM Blakely, J Suzuki, YT Chou, SM Ali, ...
The Journal of clinical investigation 132 (13), 2022
232022
Long non-coding RNA ESCCAL-1 promotes esophageal squamous cell carcinoma by down regulating the negative regulator of APOBEC3G
CW Liu Jia, Mayekar Manasi K, Wu Wei, Yan Ming, Guan Hongya, Wang Jinwu ...
Cancer Letters, 2020
212020
Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance
BioRxiv, 2020
18*2020
Synthetic essentiality of metabolic regulator PDHK1 in PTEN-deficient cells and cancers
N Chatterjee, E Pazarentzos, MK Mayekar, P Gui, DV Allegakoen, ...
Cell reports 28 (9), 2317-2330. e8, 2019
182019
Betacellulin drives therapy resistance in glioblastoma
QW Fan, Z An, RA Wong, X Luo, ED Lu, A Baldwin, MK Mayekar, ...
Neuro-oncology 22 (4), 457-469, 2020
112020
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
DR Caswell, P Gui, MK Mayekar, EK Law, O Pich, C Bailey, J Boumelha, ...
Nature Genetics 56 (1), 60-73, 2024
92024
The role of APOBEC3B in lung tumour evolution and targeted therapy resistance
DR Caswell, MK Mayekar, P Gui, EK Law, NI Vokes, CM Ruiz, M Dietzen, ...
bioRxiv, 2020.12. 18.423280, 2020
22020
Abstract LB124: APOBEC3B fuels evolution of resistance during targeted cancer therapy
MK Mayekar, D Caswell, N Vokes, W Wu, C McCoach, C Blakely, ...
Cancer Research 81 (13_Supplement), LB124-LB124, 2021
2021
APOBEC3B and TKI resistance in EGFR mutant lung cancer
D Caswell, M Mayekar, E Law, W Hill, E Gronroos, R Harris, T Bivona, ...
Cancer Research 81 (13_Supplement), 2938-2938, 2021
2021
B15 COP1 E3 Ligase Modulates Response to Oncogenic MAPK Pathway Inhibition
MK Mayekar, L Lin, TG Bivona
Journal of Thoracic Oncology 15 (2), S32, 2020
2020
Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and Cancers.
E Pazarentzos, M Mayekar, P Gui, D Allegakoen, G Hrustanovic, V Olivas, ...
Cell Reports 28 (9), 2019
2019
COP1 E3 ligase regulates response to oncogenic MAPK pathway inhibition
MK Mayekar, L Lin, TG Bivona
Cancer Research 78 (13_Supplement), 920-920, 2018
2018
Abstract LB-124: COP1 E3 ligase modulates response to oncogenic MAPK pathway inhibition
MK Mayekar, T Bivona
Cancer Research 77 (13_Supplement), LB-124-LB-124, 2017
2017
Abstract PR02: C/EBPG: A critical stress response regulator with a pro-oncogenic role
MK Mayekar, CJ Huggins, N Martin, KL Saylor, M Gonit, P Jailwala, ...
Cancer Research 76 (3_Supplement), PR02-PR02, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20